Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTA) Operating Leases (2020 - 2025)

Strata Critical Medical (SRTA) has disclosed Operating Leases for 6 consecutive years, with $3.3 million as the latest value for Q4 2025.

  • Quarterly Operating Leases rose 41.57% to $3.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.3 million through Dec 2025, up 41.57% year-over-year, with the annual reading at $3.3 million for FY2025, 41.57% up from the prior year.
  • Operating Leases for Q4 2025 was $3.3 million at Strata Critical Medical, up from $2.8 million in the prior quarter.
  • The five-year high for Operating Leases was $25.5 million in Q1 2024, with the low at $95000.0 in Q2 2021.
  • Average Operating Leases over 5 years is $11.1 million, with a median of $6.1 million recorded in 2022.
  • The sharpest move saw Operating Leases skyrocketed 6438.74% in 2022, then plummeted 88.16% in 2024.
  • Over 5 years, Operating Leases stood at $278000.0 in 2021, then skyrocketed by 5284.89% to $15.0 million in 2022, then surged by 31.85% to $19.7 million in 2023, then tumbled by 88.16% to $2.3 million in 2024, then skyrocketed by 41.57% to $3.3 million in 2025.
  • According to Business Quant data, Operating Leases over the past three periods came in at $3.3 million, $2.8 million, and $5.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.